Attys Get $18.8M In Allergan, Merz 'Pay-For-Delay' Settlement
Plaintiffs counsel in a class action from consumers who alleged Allergan and Merz delayed generic versions of Alzheimer's drugs from coming to market will be awarded 33.3%, plus litigation expense reimbursement, of...To view the full article, register now.
Already a subscriber? Click here to view full article